Skip to content

A study to see the efficacy of sympathetic nerve block in management of head, neck cancer pain.

Effect of Stellate Ganglion Block in management of Cancer Pain involving Head, Neck ,Upper Extremity and Chest wall region. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024562
Enrollment
30
Registered
2020-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

Interventions

Intervention1: Stelate ganglion block: Fluoroscopy guided stelate ganglion block will be done using 5ml of 2% preservative free lignocaine and 8 mg dexamethasone for a single episode. Control Interven

Sponsors

ESI Institute of Pain Management
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All head, neck ,upper extremity & chest wall region cancer patients having pain. 2. pain score NRS 6 or above. 3. Received pharmacological treatment for at least 4 weeks for pain management.

Exclusion criteria

Exclusion criteria: 1. Infection 2. Coagulation disorders. 3. Psychiatric disorder patients 4. Those who have Respiratory diseases. 5. Patients with a history of vocal cord paralysis on the non-surgical side, patients with a history of severe difficulty swallowing 6. Patients with distorted neck anatomy 7. Patients suffering from any type of cardiac disease.

Design outcomes

Primary

MeasureTime frame
Pain score using NRSTimepoint: Prior to the procedure and after 7 days and 1 month after the procedure.

Secondary

MeasureTime frame
EQ5D QuestionnaireTimepoint: Prior to the procedure and after 7 days and 1 month after the procedure.

Countries

India

Contacts

Public ContactDr Subrata Goswami

ESI Institute of Pain Management

drsgoswami@gmail.com09830430430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026